Additional risk factors for in-hospital ischemic stroke. Hypercoagulation syndrome

Abstract

The risk of ischemic stroke in inpatients is higher than in the general population. This is due to both the greater comorbidity of inpatients and the presence of additional risk factors, the most studied of which are iatrogenic interventions. At the same time, the higher the probability of developing an ischemic stroke, the more risk factors the patient has. An important link in the pathogenesis of in-hospital ischemic stroke is the activation of the hemostasis system, which is an obligate consequence of a typical pathological process underlying diseases and injuries that led to hospitalization: blood loss, inflammation, mechanical tissue damage, dehydration, etc. In foreign literature, this condition is attributed to the group of acquired thrombophilia, in domestic literature the term hypercoagulation syndrome has become more widespread. Iatrogenic effects can also play an important role in the pathogenesis of hypercoagulation syndrome. It is characterized by increased readiness for thrombosis, clinical and laboratory signs of hypercoagulation, activation of various factors and components of coagulation, decreased fibrinolysis, but without the development of acute thrombosis. Hypercoagulation syndrome is rarely assessed in routine practice as a risk factor for ischemic stroke, however, it can act as an additional and main risk factor for the development of all subtypes of ischemic stroke (according to the TOAST classification), including the ESUS concept. In this regard, it is advisable to distinguish in its structure: chronic (existing before hospitalization: hereditary and/or acquired) and acute (situational, developed as a result of the underlying disease, its complications or iatrogenic effects) hypercoagulation syndromes. To designate a group of acute pathological conditions predisposing to the development of hypercoagulation syndrome, systemic and/or local thrombotic complications, including in-hospital ischemic stroke, and requiring increased preventive measures, it seems pathogenetically justified, understandable and convenient to use the term situational hypercoagulation conditions (1 table, bibliography: 19 refs)

Keywords

acute stroke / antithrombotic prevention / hypercoagulation syndrome / iatrogenic effects / in-hospital ischemic stroke / perioperative stroke / situational hypercoagulation conditions

References

[1] Kolomentsev SV, Odinak MM, Voznyuk IA, et al. Ischemic stroke in hospitalized patients. The modern view on the problem. Bulletin of the Russian Military Medical Academy. 2017;(2):206–212. (In Russ.)

[2] Коломенцев С.В., Одинак М.М., Вознюк И.А., и др. Ишемический инсульт у стационарного пациента. Современный взгляд на состояние проблемы // Вестник Российской Военно-медицинской академии. 2017. № 2. С. 206–212.

[3] Mashour GA, Moore LE, Lele AV, Robicsek SA, Gelb AW. Perioperative care of patients at high risk for stroke during or after non-cardiac, non-neurologic surgery: consensus statement from the Society for Neuroscience in Anesthesiology and Critical Care. J Neurosurg Anesthesiol. 2014;26(4):273–285. DOI: https://doi.org/10.1097/ANA.00000000000000873

[4] Mashour G.A., Moore L.E., Lele A.V., Robicsek S.A., Gelb A.W. Perioperative care of patients at high risk for stroke during or after non-cardiac, non-neurologic surgery: consensus statement from the Society for Neuroscience in Anesthesiology and Critical Care // J. Neurosurg. Anesthesiol. 2014. Vol. 26, No. 4. P. 273–285. DOI: https://doi.org/10.1097/ANA.0000000000000087

[5] Vorobyev AI, Vasiliev SA, Gorodetsky VM, et al. Hypercoagulation syndrome: classification, pathogenesis, diagnosis, therapy. Russian journal of hematology and transfusiology. 2016;61(3):116–122. (In Russ.) DOI: 10.18821/0234-5730-2016-61-3-116-122

[6] Воробьев А.И., Васильев С.А., Городецкий В.М., и др. Гиперкоагуляционный синдром: классификация, патогенез, диагностика, терапия // Гематология и трансфузиология. 2016. Т. 61, № 3. С. 116–122. DOI: 10.18821/0234-5730-2016-61-3-116-122

[7] Kleindorfer DO, Towfighi A, Chaturvedi S, et al. Guideline for the Prevention of Stroke in Patients with Stroke and Transient Ischemic Attack. A Guideline from the American Heart Association/American Stroke Association. Stroke. 2021;52(7): e364–e467. DOI: 10.1161/STR.0000000000000375

[8] Kleindorfer D.O., Towfighi A., Chaturvedi S., et al. Guideline for the Prevention of Stroke in Patients with Stroke and Transient Ischemic Attack. A Guideline from the American Heart Association/American Stroke Association // Stroke. 2021. Vol. 52, No. 7. P. e364–e467. DOI: 10.1161/STR.0000000000000375

[9] Shi Z, Zheng WC, Yang H, et al. Contribution of dehydration to END in acute ischemic stroke not mediated via coagulation activation. Brain Behav. 2019;9(6): e01301. DOI: 10.1002/brb3.1301

[10] Shi Z., Zheng W.C., Yang H., et al. Contribution of dehydration to END in acute ischemic stroke not mediated via coagulation activation // Brain Behav. 2019. Vol. 9, No. 6. P. e01301. DOI: 10.1002/brb3.1301

[11] Weiser TG, Haynes AB, Molina G, et al. Size and distribution of the global volume of surgery in 2012. Bull World Health Organ. 2016;94(3):201–209F. DOI: 10.2471/BLT.15.159293

[12] Weiser T.G., Haynes A.B., Molina G., et al. Size and distribution of the global volume of surgery in 2012 // Bull. World Health. Organ. 2016. Vol. 94, No. 3. P. 201–209. DOI: 10.2471/BLT.15.159293

[13] Donze JD, Ridker PM, Finlayson SR, Bates DW. Impact of sepsis on risk of postoperative arterial and venous thromboses: large prospective cohort study. BMJ. 2014;349:5334. DOI: 10.1136/bmj.g5334

[14] Donze J.D., Ridker P.M., Finlayson S.R., Bates D.W. Impact of sepsis on risk of postoperative arterial and venous thromboses: large prospective cohort study // BMJ. 2014. No. 349. P. 5334. DOI: 10.1136/bmj.g5334

[15] Ovechkin AM, Romanova TL. Postoperative analgesia: optimization approaches from the point of view of evidence-based medicine. Russian Medical Journal. 2006;14(12):865–872.

[16] Овечкин А.М., Романова Т.Л. Послеоперационное обезболивание: оптимизация подходов с точки зрения доказательной медицины // Русский медицинский журнал. 2006. Т. 14, № 12. С. 865–872.

[17] Beristain-Covarrubias N, Perez-Toledo M, Thomas MR, et al. Understanding Infection-Induced Thrombosis: Lessons Learned From Animal Models. Front Immunol. 2019;(10):2569.

[18] Beristain-Covarrubias N., Perez-Toledo M., Thomas M.R., et al. Understanding Infection-Induced Thrombosis: Lessons Learned From Animal Models // Front. Immunol. 2019. No. 10. P. 2569.

[19] Zakharov SM, Chechneva MA, Budykina TS. Hypercoagulation conditions and pregnancy. Russian Bulletin of the obstetrician-gynecologist. 2019;19(1):33–37.

[20] Захаров С.М., Чечнева М.А., Будыкина Т.С. Гиперкоагуляционные состояния и беременность // Российский вестник акушера-гинеколога. 2019. Т. 19, № 1. С. 33–37.

[21] James AH, Bushnell CD, Jamison MG, Myers ER. Incidence and risk factors for stroke in pregnancy and the puerperium. Obstet Gynecol. 2005;106(3):509–516.

[22] James A.H., Bushnell C.D., Jamison M.G., Myers E.R. Incidence and risk factors for stroke in pregnancy and the puerperium // Obstet. Gynecol. 2005. Vol. 106, No. 3. P. 509–516.

[23] Soriano D, Carp H, Seidman DS, et al. Management and outcome of pregnancy in women with thrombophylic disorders and past cerebrovascular events. Acta Obstet Gynecol Scand. 2002;81(3):204–207.

[24] Soriano D., Carp H., Seidman D.S., et al. Management and outcome of pregnancy in women with thrombophylic disorders and past cerebrovascular events // Acta Obstet. Gynecol. Scand. 2002. Vol. 81, No. 3. P. 204–207.

[25] Scolnoki Z, Somogyvari F, Kondacs A, Szabo M, Fodor L. Evalution of the rioles of the Leiden V mutation and ACE I/D polymorphism in subtypes of ishaemic stroke. J Neurol. 2001;248(9):756–761.

[26] Scolnoki Z., Somogyvari F., Kondacs A., Szabo M., Fodor L. Evalution of the rioles of the Leiden V mutation and ACE I/D polymorphism in subtypes of ishaemic stroke // J. Neurol. 2001. Vol. 248, No. 9. P. 756–761.

[27] Sinenchenko GI, Selivanov EA, Musinov IM. The state of the hemostasis system in ulcerative gastrointestinal bleeding. Vestnik khirurgii imeni I.I. Grekova. 2006;165(2):15–19. (In Russ.)

[28] Синенченко Г.И., Селиванов Е.А., Мусинов И.М. Состояние системы гемостаза при язвенных желудочно-кишечных кровотечениях // Вестник хирургии им. И.И. Грекова. 2006. Т. 165, № 2. С. 15–19.

[29] Yesin RG, Yesin OR, Khakimova AR. Stress-induced disorders. Neuroscience and Behavioral Physiology. 2020;120(5):131–137.

[30] Есин Р.Г., Есин О.Р., Хакимова А.Р. Стресс-индуцированные расстройства // Журнал неврологии и психиатрии им. С.С. Корсакова. 2020. T. 120, № 5. С. 131–137.

[31] Von Känel R. Acute mental stress and hemostasis: When physio logy becomes vascular harm. Thrombosis Research. 2015;135:52–55.

[32] Von Känel R. Acute mental stress and hemostasis: When physiology becomes vascular harm // Thrombosis Research. 2015. No. 135. P. 52–55.

[33] Austin A, Wissmann T, von Kanel R. Stress and Hemostasis: An Update. Seminars in Thrombosis and Hemostasis. 2013;39(8):902–912.

[34] Austin A., Wissmann T., von Kanel R. Stress and Hemostasis: An Update // Seminars in Thrombosis and Hemostasis. 2013. Vol. 39, No. 8. P. 902–912.

[35] Kryukov EV, Potekhin NP, Fursov AN, et al. Comparative characteristics of patients suffering from arterial hypertension and stenosing atherosclerosis, depending on the localization of the pathological process in the bloodstream. Bulletin of the Russian Military Medical Academy. 2020;1(69):36–38. (In Russ.)

[36] Крюков Е.В., Потехин Н.П., Фурсов А.Н., и др. Сравнительная характеристика больных, страдающих артериальной гипертензией и стенозирующим атеросклерозом, в зависимости от локализации патологического процесса в сосудистом русле // Вестник Российской Военно-медицинской академии. 2020. № 1 (69). С. 36–38.

[37] Moroz EV, Karateev AE, Kryukov EV, Chernetsov VA. Gastrointestinal bleeding associated with the use of the new oral anticoagulants: epidemiology, risk factors, treatment and prevention. Nauchno-prakticheskaya revmatologiya. 2017;55(6): 675–684.

[38] Мороз Е.В., Каратеев А.Е., Крюков Е.В., Чернецов В.А. Желудочно-кишечные кровотечения при использовании новых пероральных антикоагулянтов: эпидемиология, факторы риска, лечение и профилактика // Научно-практическая ревматология. 2017. Т. 55, № 6. С. 675–684.

RIGHTS & PERMISSIONS

Kolomentsev S.V., Shermatyuk E.I., Tsygan N.V., Voznyuk I.A., Yanishevsky S.N., Odinak M.M., Litvinenko I.V.